Kinetics of C-Reactive Protein During the Management of Acute Coronary Syndrome Treated by Transluminal Angioplasty
CRP KIN
2 other identifiers
observational
35
1 country
2
Brief Summary
The primary objective of the study focuses on the kinetics of plasma CRP measured during the overall management (before the angioplasty procedure until the discharge of hospitalization) of patients with ST+ ACS requiring emergency transluminal angioplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2022
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2022
CompletedFirst Posted
Study publicly available on registry
February 10, 2022
CompletedStudy Start
First participant enrolled
March 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedOctober 1, 2025
September 1, 2025
2.1 years
January 28, 2022
September 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma CRP kinetic
Blood sampling: Pre-angioplasty, on H6, H12, H24, H48 and once a day post angioplasty until the 7th day; then once a week until discharge from hospital with a maximum of 30 days
Pre-angioplasty, hour 6, hour 12, hour 24, hour 48 and daily post angioplasty until day 7 then weekly untill day 30
Eligibility Criteria
Adult patients cared for ST+ ACS requiring emergency transluminal angioplasty.
You may qualify if:
- Age over 18 years old;
- ST+ ACS requiring emergency transluminal angioplasty;
- Affiliation to a social security scheme or beneficiary.
You may not qualify if:
- ST+ ACS not requiring emergency transluminal angioplasty;
- Pregnancy;
- Under guardianship or curatorship;
- Foreign patient under french AME scheme.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Cardiology department, Ambroise Paré hospital, APHP
Boulogne-Billancourt, 92100, France
Intensive care unit, Ambroise Paré hospital, APHP
Boulogne-Billancourt, 92100, France
Related Publications (1)
Milwidsky A, Ziv-Baran T, Letourneau-Shesaf S, Keren G, Taieb P, Berliner S, Shacham Y. CRP velocity and short-term mortality in ST segment elevation myocardial infarction. Biomarkers. 2017 May-Jun;22(3-4):383-386. doi: 10.1080/1354750X.2017.1279218. Epub 2017 Jan 25.
PMID: 28055283BACKGROUND
Biospecimen
C reactive protein (CRP) sampling
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Romain Jouffroy, MD, PhD
Intensive Care Unit - Ambroise Paré Hospital - APHP
- STUDY DIRECTOR
Marie Hauguel-Moreau, MD
Cardiology department, Ambroise Paré hospital, APHP
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2022
First Posted
February 10, 2022
Study Start
March 2, 2022
Primary Completion
April 1, 2024
Study Completion
April 1, 2024
Last Updated
October 1, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share